Cargando…
Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ
Drug resistance is a major cause of treatment failure in pancreatic cancer. The limited evidence indicates the involvement of miR-455-3p in chemotherapy resistance of cancer. Here we observed by qPCR that miR-455-3p was significantly decreased in pancreatic cancer tissues and cell lines. We then con...
Autores principales: | Zhan, Ting, Huang, Xiaodong, Tian, Xia, Chen, Xiaoli, Ding, Yu, Luo, Hesheng, Zhang, Yadong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862130/ https://www.ncbi.nlm.nih.gov/pubmed/29499934 http://dx.doi.org/10.1016/j.omtn.2017.12.002 |
Ejemplares similares
-
miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer
por: Zhan, Ting, et al.
Publicado: (2020) -
Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA‐455
por: Xu, Baoli, et al.
Publicado: (2019) -
miR-324-5p Contributes to Cell Proliferation and Apoptosis in Pancreatic Cancer by Targeting KLF3
por: Wan, Yiyuan, et al.
Publicado: (2020) -
MicroRNA-140-5p is Downregulated in Osteosarcoma and Overexpression of MicroRNA-140-5p Inhibits Cancer Cell Proliferation by Downregulating GLUT-1
por: Geng, Xiaoling, et al.
Publicado: (2021) -
MicroRNA-455-3p regulates proliferation and osteoclast differentiation of RAW264.7 cells by targeting PTEN
por: Zhang, Xiaolu, et al.
Publicado: (2022)